期刊文献+

醌氧化还原酶1基因多态性与肝癌易感性关系研究 被引量:1

Association of NQO1 Gene Polymorphism with Susceptibility of Hepatocellular Carcinoma
下载PDF
导出
摘要 目的探讨肝癌易感性与醌氧化还原酶1(NQO1)基因多态性的关系。方法以桂林医学院附属医院136例肝癌患者为病例组,选择同期该院的123例无肿瘤患者为对照组,进行肝癌相关危险因素的问卷调查,应用荧光探针(Taqman MGB)技术检测NQO1基因609位点的多态性。结果 NQO1基因3种基因型在两组间差异有统计学意义(χ2=17.345,P<0.05),且携带有NQO1突变杂合子(C/T)和突变纯合子(T/T)的个体发生肝癌的危险性较携带野生纯合子(C/C)个体高,NQO1基因携带突变基因型T与经常吸烟可以增加罹患肝癌风险[OR=2.643,95%CI(1.379,5.066)]。结论 NQO1基因多态性在肝癌发生过程中,突变基因型可能是一个危险因素,且与吸烟存在协同作用。 Objective To study the relationship between the polymorphisms of NQO1 and the susceptibility of hepatocellular carcinoma(HCC). Methods The research was a case-control study which included 136 cases of HCC in case group and 123 cases without tumor in control group,all receiving questionnaires about the risk factors for liver cancer.609 sites of NQO1 polymorphisms were determined by polymerase chain restriction with Taqman MGB probe. Results Three types of gene among NQO1 were significantly different between the two groups(χ2=17.345,P<0.05)and the cases with mutation homozygote(C/T)and mutation heterozygote(T/T)had higher risks for liver cancer than those wild homozygote.NQ01 with mutation allele(T)and smoking were high risk factors for liver cancer[OR=2.643,95%CI(1.379,5.066)]. Conclusion NQO1 mutation genotype may be a risk factor and will have a synergistic influence together with smoking in the formation of liver cancer.
机构地区 桂林医学院
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第12期1369-1371,共3页 Chinese General Practice
基金 吴阶平医学基金(LDWMF-SY-2011C009) 广西研究生科研创新项目基金[桂学位(2011)35号557]
关键词 肝肿瘤 醌还原酶类 多态性 单核苷酸 疾病易感性 Liver neoplasmas Quinone reductases Polymorphism,single necleotide Disease susceptibility
  • 相关文献

参考文献4

二级参考文献24

  • 1Cavalieri E, Rogan E, Chakravarti D. The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. Methods Enzymol,2004, 382 : 293-319.
  • 2Sarbia M, Bitzer M, Siegel D, et al. Association between NAD (P)H: quinone oxidoreductase 1 ( NQ01 ) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.Int J Cancer,2003, 107 : 381-386.
  • 3Sommer SS, Groszbach AR, Bottema CD. PCR amplification of specific alleles (PASA) is a general method for rapidly detecting known single-base changes. Biotechniques, 1992,12:82-87.
  • 4Nioi P, Hayes JD. Contribution of NAD (P) H: quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrt2 basic-region leucine zipper and the arylhydrecarbon receptor basic helix-loop-helix transcription factors. Mutat Res, 2004, 555: 149-171.
  • 5Phillips RM, Basu S. Biological and Clinical Significance of Polymorphisms in NAD(P) H : Quinone Oxidoreductase 1 ( NQO1 ).Current Pharmacogenomics, 2004, 2: 75-82.
  • 6Chen S,Wu K B,Richard Knox.Structure-function studies of DT-diaphorase (NQO1) and NRH quinone oxidoreductase (NQO2)[J].Free Radical Biology & Medicine,2000,29 (4):276-284.
  • 7Tara Fryatt,Hanna I.Pettersson,Walter T,et al.Novel quinolinequinone antitumor agents:structure metabolism studies with NAD (P) H:quinone oxidoreductase (NQO1)[J].Bioorganic &Medicinal Chemistry,2004,12 (7):1667-1687.
  • 8Yin L H,Pu Y P,Liu T Y.Genetic polymorphisms of NAD (P)H quinine oxidoreductase,CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing[J].China.Lung Cancer,2001,33 (2-3):133-141.
  • 9Lin P P,Wang H J,Lee H.NAD (P):quinone oxidoreductase polymorphism and lung cancer in Taiwan[J].Toxicol Environ Health,1999,58 (4):187-197.
  • 10Wiencke J K,Spitz M R,McMillian A.Lung Cancer in Mexican-Americans and African-Americans iassociated with the wild-type genotype of the NAD (P) H:quinone oxidoreductase polymorphism[J].Cancer Epidemiol Biomark & Prevent,1997,6 (2):87-92.

共引文献15

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部